{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:13:00Z","timestamp":1789125180790,"version":"build-2803163510"},"posted":{"date-parts":[[2026,9,11]]},"group-title":"In Review","reference-count":18,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,30]]},"abstract":"<title>Abstract<\/title>\n                <p>244 words Introduction: Cervical cancer occurs in women with pelvic organ prolapse (POP), but the prevalence of cervical cancer screening (CCS) in this population is unknown. We hypothesize that age, race, ethnicity, and college attendance will impact CCS for women with POP. Methods: In this cross-sectional study, we extracted CCS laboratory codes from an electronic healthcare database, Truveta, between 2017 and 2022 for women aged 21-65 who were without a hysterectomy or prior gynecologic cancer. We extracted POP data based on medical codes. Results: Among 2,265,395 eligible women, we found a 4.4\/1000 prevalence of POP among women aged 21-65 years who were eligible for CCS. Women with POP are significantly older (50-65 years old: 63.8% vs 35.2%, p&lt;0.001), White (84.5% vs 73.6%, p&lt;0.001), and have less college education (43.2% vs 59.9%, p&lt;0.001) than women without POP. CCS among women with POP was greater than in women without POP (72.6% vs 70.8%, p&lt;0.001). In analyses adjusted for age, race, ethnicity, and college education, they were 56% more likely to have CCS (aOR=1.56 (95% CI: 1.44, 1.77), p&lt;0.001) than women without POP. In addition, Asian, Black, Hispanic, and White women with POP had greater adjusted odds of CCS than their respective groups without POP. Conclusion: Women with POP have greater CCS rates than those without. CCS rates for women with POP who are 50 and older, the age group at highest risk for cervical cancer, are still below the Healthy People 2030 (HP2030) goals for cervical cancer screening.<\/p>","DOI":"10.21203\/rs.3.rs-10537590\/v1","type":"posted-content","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:58:52Z","timestamp":1789124332000},"source":"Crossref","is-referenced-by-count":0,"title":["Cervical cancer screening among US women with pelvic organ prolapse"],"prefix":"10.21203","author":[{"given":"Carla L Da Goia","family":"Pinto","sequence":"first","affiliation":[{"name":"University of Illinois Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Crespo-Albiac","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara Master","family":"Hunter","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lin","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Moureau","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Kamdar","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Streur","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane M","family":"Harper","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Increase the proportion of females who get screened for cervical cancer - C-09. 2024. https:\/\/odphp.health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/cancer\/increase-proportion-females-who-get-screened-cervical-cancer-c-09"},{"key":"ref2","unstructured":"SEER cervical cancer data. 2020\u20134 https:\/\/seer.cancer.gov\/statfacts\/html\/cervix.html"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"105880","DOI":"10.1016\/j.ypmed.2019.105880.","article-title":"Three large-scale surveys highlight the complexity of cervical cancer under-screening among women 45-65years of age in the United States","volume":"130","author":"Harper DM","year":"2020","unstructured":"Harper DM, Plegue M, Harmes KM, Jimbo M, SheinfeldGorin S. Three large-scale surveys highlight the complexity of cervical cancer under-screening among women 45-65years of age in the United States. Prev Med. 2020;130:105880. 10.1016\/j.ypmed.2019.105880. . Epub 2019 Nov 1. PMID: 31678587; PMCID: PMC8088237.","journal-title":"Prev Med"},{"issue":"6","key":"ref4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/nursrep15060212.","article-title":"Uterine Prolapse Across the Female Lifespan: Clinical Insights and Practical Considerations from Greece","volume":"15","author":"Loukopoulou A","year":"2025","unstructured":"Loukopoulou A, Tzanni E, Bothou A, Billis E, Nanou C, Kyrkou G, Vivilaki V, Deltsidou A. Uterine Prolapse Across the Female Lifespan: Clinical Insights and Practical Considerations from Greece. Nurs Rep. 2025;15(6):212. 10.3390\/nursrep15060212. . PMID: 40559503; PMCID: PMC12196526.","journal-title":"Nurs Rep"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1007\/s00192-021-04858-z","article-title":"Prevalence of histological abnormalities in hysterectomy specimens performed for prolapse. A systematic review and meta-analysis","volume":"32","author":"Nicholson RC","year":"2021","unstructured":"Nicholson RC, Khunda A, Ballard P, Rees J, McCormick C. Prevalence of histological abnormalities in hysterectomy specimens performed for prolapse. A systematic review and meta-analysis. Int Urogynecol J. 2021;32(12):3131\u201341.","journal-title":"Int Urogynecol J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00404-025-08135-y","article-title":"The prevalence and clinical relevance of cervical abnormalities after an amputation of the cervix as part of prolapse surgery: a cross-sectional study","volume":"312","author":"Cooten VV","year":"2025","unstructured":"van Cooten VV, van Hamont D, Siebers AG, et al. The prevalence and clinical relevance of cervical abnormalities after an amputation of the cervix as part of prolapse surgery: a cross-sectional study. Arch Gynecol Obstet. 2025;312:1287\u201394. https:\/\/doi.org\/10.1007\/s00404-025-08135-y.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"ref7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.18502\/ijph.v53i3.15134.","article-title":"Worldwide Prevalence of Pelvic Organ Prolapse: A Systematic Review and Meta-Analysis","volume":"53","author":"Hadizadeh-Talasaz Z","year":"2024","unstructured":"Hadizadeh-Talasaz Z, Khadivzadeh T, Mohajeri T, Sadeghi M. Worldwide Prevalence of Pelvic Organ Prolapse: A Systematic Review and Meta-Analysis. Iran J Public Health. 2024;53(3):524\u201338. 10.18502\/ijph.v53i3.15134. . PMID: 38919293; PMCID: PMC11194659.","journal-title":"Iran J Public Health"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/AOG.0000000000000057","article-title":"Prevalence and trends of symptomatic pelvic floor disorders in US women","volume":"123","author":"Wu JM","year":"2014","unstructured":"Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, Markland AD. Prevalence and trends of symptomatic pelvic floor disorders in US women. Obstet Gynecol. 2014;123(1):141\u20138. PMID: 24463674; PMCID: PMC3970401.","journal-title":"Obstet Gynecol"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s00192-021-04983-9","article-title":"Racial and ethnic representation in primary research contributing to pelvic organ prolapse treatment guidelines","volume":"32","author":"Brandon CA","year":"2021","unstructured":"Brandon CA, Barlow LJ, Oh C, Sackrison A, Brucker BM. Racial and ethnic representation in primary research contributing to pelvic organ prolapse treatment guidelines. Int Urogynecol J. 2021;32(11):2959\u201367.","journal-title":"Int Urogynecol J"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement","volume":"156","author":"Moyer VA","year":"2012","unstructured":"Moyer VA, US Preventive Services Task Force. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;156(12):880\u201391. W312.","journal-title":"Ann Intern Med"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement","volume":"320","author":"Curry SJ","year":"2018","unstructured":"US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Tseng CW, Wong JB. Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(7):674\u201386.","journal-title":"JAMA"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00192-021-05018-z","article-title":"International urogynecology consultation Chap. 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs","volume":"33","author":"Brown HW","year":"2022","unstructured":"Brown HW, Hegde A, Huebner M, Neels H, Barnes HC, Marquini GV, Mukhtarova N, Mbwele B, Tailor V, Kocjancic E, Trowbridge E, Hayward L. International urogynecology consultation Chap. 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs. Int Urogynecol J. 2022;33(2):173\u201387.","journal-title":"Int Urogynecol J"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1001\/jama.300.11.1311","article-title":"Pelvic Floor Disorders Network. Prevalence of symptomatic pelvic floor disorders in US women","volume":"300","author":"Nygaard I","year":"2008","unstructured":"Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, Spino C, Whitehead WE, Wu J, Brody DJ. Pelvic Floor Disorders Network. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300(11):1311\u20136.","journal-title":"JAMA"},{"issue":"1","key":"ref14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12920-023-01560-5.","article-title":"Evaluation for causal effects of socioeconomic traits on risk of female genital prolapse (FGP): a multivariable Mendelian randomization analysis","volume":"16","author":"Zhang W","year":"2023","unstructured":"Zhang W, Ge J, Qu Z, Wu W, Lei H, Pan H, Chen H. Evaluation for causal effects of socioeconomic traits on risk of female genital prolapse (FGP): a multivariable Mendelian randomization analysis. BMC Med Genomics. 2023;16(1):125. 10.1186\/s12920-023-01560-5. . PMID: 37296408; PMCID: PMC10251634.","journal-title":"BMC Med Genomics"},{"key":"ref15","author":"Cervical Cancer","unstructured":"Cervical Cancer. Screening from 1987\u20132023. https:\/\/progressreport.cancer.gov\/detection\/cervical_cancer"},{"issue":"1","key":"ref16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s12885-025-14049-4.","article-title":"Prevalence of HPV infection and cervical lesions among women with pelvic organ prolapse and implications for preoperative evaluation","volume":"25","author":"Ge Y","year":"2025","unstructured":"Ge Y, Wu F, Zhang Y, Wang X, Wu G. Prevalence of HPV infection and cervical lesions among women with pelvic organ prolapse and implications for preoperative evaluation. BMC Cancer. 2025;25(1):624. 10.1186\/s12885-025-14049-4. . PMID: 40197139; PMCID: PMC11974025.","journal-title":"BMC Cancer"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/nau.24672","article-title":"Prevalence of pelvic organ prolapse among US racial populations: A systematic review and meta-analysis of population-based screening studies","volume":"40","author":"Mou T","year":"2021","unstructured":"Mou T, Warner K, Brown O, Yeh C, Beestrum M, Kenton K, Emi Bretschneider C. Prevalence of pelvic organ prolapse among US racial populations: A systematic review and meta-analysis of population-based screening studies. Neurourol Urodyn. 2021;40(5):1098\u2013106.","journal-title":"Neurourol Urodyn"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"102971","DOI":"10.1016\/j.pmedr.2025.102971.","article-title":"Cervical cancer screening: Impact of collection technique on human papillomavirus detection and genotyping","volume":"50","author":"Young AP","year":"2025","unstructured":"Young AP, Olorunfemi M, Morrison L, Kelley SA, Laurie A, McEvoy A, Schneiderhan J, Prussack J, O'Dwyer MC, Rockwell P, Zazove P, Gabison J, Chargot J, Gallagher K, Sen A, Chen D, Haro EA, Butcher EA, Alves ML, El Khoury C, Dendrinos ML, Brashear N, Smith R, Lieberman RW, Saunders N, Campbell E, Walline HM, Harper DM. Cervical cancer screening: Impact of collection technique on human papillomavirus detection and genotyping. Prev Med Rep. 2025;50:102971. 10.1016\/j.pmedr.2025.102971. . PMID: 39906308; PMCID: PMC11791345.","journal-title":"Prev Med Rep"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10537590\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10537590\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:58:55Z","timestamp":1789124335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10537590\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":18,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10537590\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,9,11]]},"subtype":"preprint"}}